CalciMedica
CALC
28 hedge funds and large institutions have $20.7M invested in CalciMedica in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 6 closing their positions.
133% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 3
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
4% more funds holding
Funds holding: 27 → 28 (+1)
2% more call options, than puts
Call options by funds: $537K | Put options by funds: $527K
44% less capital invested
Capital invested by funds: $37M → $20.7M (-$16.4M)
Top Buyers
| 1 |
Two Sigma Investments
New York
|
+$259K |
| 2 |
Morgan Stanley
New York
|
+$248K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$239K |
| 4 |
Two Sigma Advisers
New York
|
+$72.1K |
| 5 |
State Street
Boston,
Massachusetts
|
+$40.3K |
Top Sellers
CALC Hedge Fund Activity: Q4 2021 in Review
28 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q4 2021, worth a combined $20.7M — down 44% from $37M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CALC positions and 6 closed out — a net gain of 1 holder — while 7 added to existing stakes and 3 trimmed.
The largest buyer was Two Sigma Investments, opening a new position worth an estimated $259K. The largest seller was JP Morgan Chase, exiting entirely with an estimated $358K sold.
- 28 institutional investors held CalciMedica (CALC) as of Q4 2021, up from 27 in Q3 2021.
- Funds reported $20.7M of CalciMedica stock for Q4 2021, down 44% quarter-over-quarter.
- 7 funds opened new CalciMedica positions in Q4 2021 and 6 closed out, a net change of +1 holder.
- The largest CalciMedica buyer in Q4 2021 was Two Sigma Investments, an estimated $259K added.
- The largest CalciMedica seller in Q4 2021 was JP Morgan Chase, an estimated $358K sold.
Based on aggregated 13F filings for Q4 2021.